Source: Catalyst Pharmaceuticals Blog

Catalyst Pharmaceuticals Blog Catalyst Pharmaceutical's Firdapse Phase 3 Study Published in Muscle & Nerve

CORAL GABLES, Fla., May 18, 2016 (GLOBE NEWSWIRE) - Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Based on data from Catalyst Pharmaceuticals's latest SEC filings

Annual Revenue

Based on data from Catalyst Pharmaceuticals's latest SEC filings

Employees

Patrick J. McEnany's photo - Chairman & CEO of Catalyst Pharmaceuticals

Chairman & CEO

Patrick J. McEnany

CEO Approval Rating

72/100

Catalyst is a specialty pharmaceutical company focused on in-licensing and developing.

Catalyst Pharmaceuticals's headqua...
Read more